Claims for Patent: 8,138,309

Summary for Patent: 8,138,309

Title:	Modified rubisco large subunit n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1,5-bisphosphate
Abstract:	The present invention generally relates to a modified Rubisco large subunit .sup..epsilon.N-Methyltransferase (Rubisco LSMT, or RLSMT). The present invention also relates to a modified RLSMT-carbonic anhydrase (RLSMT-CA). This modified RLSMT-CA improves the efficiency of the reduction of CO.sub.2 during photosynthesis, which may increase plant growth rates. The present invention also relates to nucleic acids encoding the modified RLSMT-CA or modified RLSMT. Also, the present invention relates to cells including the modified RLSMT-CA or modified RLSMT, plants containing the modified RLSMT-CA or modified RLSMT, and methods using compositions of the present invention. In addition, the present invention relates to antibodies conjugated to CA which may bind to Rubisco, and antibodies which bind a modified RLSMT-CA. The invention also relates to modified forms of the LS and SS of Rubisco where the modified forms are fusions with CA or biologically active fragments thereof. The present invention provides methods of altering Rubisco carboxylase activity and altering plant growth.
Inventor(s):	Houtz; Robert L. (Lexington, KY)
Assignee:	University of Kentucky Research Foundation (Lexington, KY)
Application Number:	12/190,246
Patent Claims:	1. A modified Rubisco large subunit .sup..epsilon.N-methyltransferase (RLSMT), comprising a Rubisco large subunit .sup..epsilon.N-methyltransferase linked to a second molecule and wherein the modified RLSMT has the ability to bind a Rubisco. 2. The modified RLSMT of claim 1, wherein the Rubisco large subunit .sup..epsilon.N-methyltransferase is linked to the second molecule by a chemical. 3. The modified RLSMT of claim 2, wherein the chemical is glutaraldehyde. 4. The modified RLSMT of claim 2, wherein the modified RLSMT is a fusion protein, wherein the fusion protein is encoded by a nucleic acid, wherein the nucleic acid comprises a first nucleic acid encoding a Rubisco large subunit .sup..epsilon.N-methyltransferase, and wherein the nucleic acid further comprises a second nucleic acid encoding a polypeptide. 5. The modified RLSMT of claim 1, wherein the second molecule is carbonic anhydrase. 6. The modified RLSMT of claim 1, wherein the second molecule is a phosphatase, 3-phosphoglycerate kinase, glyceraldehydes-3-phosphate dehydrogenase, Rubisco Activase, Phosphoribulokinase, polylysine, or oxygenase. 7. The modified RLSMT of claim 1, wherein the modified RLSMT is a fusion protein, wherein the fusion protein is encoded by a nucleic acid. 8. A modified Rubisco large subunit .sup..epsilon.N-methyltransferase of claim 1, wherein said second molecule is a carbonic anhydrase, wherein the modified RLSMT (RLSMT-CA) has the ability to bind a Rubisco large subunit. 9. The modified RLSMT of claim 8, wherein the Rubisco large subunit .sup..epsilon.N-methyltransferase is linked to the carbonic anhydrase (CA) by a chemical. 10. The modified RLSMT of claim 9, wherein the chemical is glutaraldehyde. 11. The modified RLSMT of claim 8, wherein the modified RLSMT is a fusion protein, wherein the fusion protein is encoded by a nucleic acid, wherein the nucleic acid comprises a first nucleic acid encoding a Rubisco large subunit .sup..epsilon.N-methyltransferase, and wherein the nucleic acid further comprises a second nucleic acid encoding a carbonic anhydrase. 12. The modified RLSMT of claim 8, wherein the modified RLSMT further comprises an antibody. 13. The modified RLSMT of claim 11, wherein the antibody is linked to a CA. 14. The modified RLSMT of claim 8 comprising SEQ ID No.: 2.

Details for Patent 8,138,309

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	ACTIVASE	alteplase	For Injection	103172	11/13/1987		2039-02-26
Genentech, Inc.	CATHFLO ACTIVASE	alteplase	For Injection	103172	09/04/2001		2039-02-26